Annual Cost Of Goods Sold
$705.40 M
+$12.30 M+1.77%
31 December 2023
Summary:
Emergent BioSolutions annual cost of goods sold is currently $705.40 million, with the most recent change of +$12.30 million (+1.77%) on 31 December 2023. During the last 3 years, it has risen by +$168.40 million (+31.36%). EBS annual cost of goods sold is now -5.71% below its all-time high of $748.10 million, reached on 31 December 2021.EBS Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cost Of Goods Sold
$122.60 M
-$173.50 M-58.60%
30 September 2024
Summary:
Emergent BioSolutions quarterly cost of goods sold is currently $122.60 million, with the most recent change of -$173.50 million (-58.60%) on 30 September 2024. Over the past year, it has dropped by -$54.20 million (-30.66%). EBS quarterly cost of goods sold is now -58.60% below its all-time high of $296.10 million, reached on 30 June 2024.EBS Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Cost Of Goods Sold
$748.40 M
-$54.20 M-6.75%
30 September 2024
Summary:
Emergent BioSolutions TTM cost of goods sold is currently $748.40 million, with the most recent change of -$54.20 million (-6.75%) on 30 September 2024. Over the past year, it has increased by +$7.60 million (+1.03%). EBS TTM cost of goods sold is now -7.00% below its all-time high of $804.70 million, reached on 31 March 2022.EBS TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.8% | -30.7% | +1.0% |
| 3 y3 years | +31.4% | -43.6% | +3.1% |
| 5 y5 years | +118.9% | +13.5% | +80.7% |
EBS Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -5.7% | +31.4% | -58.6% | at low | -7.0% | +10.6% |
| 5 y | 5 years | -5.7% | +118.9% | -58.6% | +59.4% | -7.0% | +80.7% |
| alltime | all time | -5.7% | +2823.9% | -58.6% | >+9999.0% | -7.0% | >+9999.0% |
Emergent BioSolutions Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $122.60 M(-58.6%) | $748.40 M(-6.8%) |
| June 2024 | - | $296.10 M(+104.8%) | $802.60 M(+15.1%) |
| Mar 2024 | - | $144.60 M(-21.9%) | $697.10 M(-1.2%) |
| Dec 2023 | $705.40 M(+1.8%) | $185.10 M(+4.7%) | $705.40 M(-4.8%) |
| Sept 2023 | - | $176.80 M(-7.2%) | $740.80 M(+4.2%) |
| June 2023 | - | $190.60 M(+24.7%) | $711.20 M(+3.0%) |
| Mar 2023 | - | $152.90 M(-30.7%) | $690.40 M(-0.4%) |
| Dec 2022 | $693.10 M(-7.4%) | $220.50 M(+49.8%) | $693.40 M(+2.5%) |
| Sept 2022 | - | $147.20 M(-13.3%) | $676.40 M(-9.4%) |
| June 2022 | - | $169.80 M(+8.9%) | $746.70 M(-7.2%) |
| Mar 2022 | - | $155.90 M(-23.4%) | $804.70 M(+7.6%) |
| Dec 2021 | $748.10 M(+39.3%) | $203.50 M(-6.4%) | $748.10 M(+3.1%) |
| Sept 2021 | - | $217.50 M(-4.5%) | $725.90 M(+10.4%) |
| June 2021 | - | $227.80 M(+129.4%) | $657.40 M(+17.5%) |
| Mar 2021 | - | $99.30 M(-45.2%) | $559.40 M(+4.2%) |
| Dec 2020 | $537.00 M(+23.9%) | $181.30 M(+21.7%) | $537.00 M(+9.9%) |
| Sept 2020 | - | $149.00 M(+14.8%) | $488.50 M(+9.2%) |
| June 2020 | - | $129.80 M(+68.8%) | $447.50 M(+6.9%) |
| Mar 2020 | - | $76.90 M(-42.1%) | $418.50 M(-3.4%) |
| Dec 2019 | $433.50 M(+34.5%) | $132.80 M(+23.0%) | $433.40 M(+4.7%) |
| Sept 2019 | - | $108.00 M(+7.1%) | $414.10 M(+10.3%) |
| June 2019 | - | $100.80 M(+9.8%) | $375.40 M(+4.3%) |
| Mar 2019 | - | $91.80 M(-19.1%) | $359.90 M(+11.6%) |
| Dec 2018 | $322.30 M(+71.7%) | $113.50 M(+63.8%) | $322.40 M(+18.9%) |
| Sept 2018 | - | $69.30 M(-18.8%) | $271.15 M(+10.1%) |
| June 2018 | - | $85.30 M(+57.1%) | $246.35 M(+25.9%) |
| Mar 2018 | - | $54.30 M(-12.8%) | $195.68 M(+4.3%) |
| Dec 2017 | $187.70 M(+48.6%) | $62.25 M(+39.9%) | $187.70 M(+18.3%) |
| Sept 2017 | - | $44.50 M(+28.5%) | $158.72 M(+3.2%) |
| June 2017 | - | $34.62 M(-25.3%) | $153.78 M(+3.5%) |
| Mar 2017 | - | $46.32 M(+39.2%) | $148.62 M(+17.7%) |
| Dec 2016 | $126.30 M(+17.5%) | $33.27 M(-15.9%) | $126.30 M(-0.9%) |
| Sept 2016 | - | $39.56 M(+34.3%) | $127.43 M(+3.5%) |
| June 2016 | - | $29.46 M(+22.8%) | $123.11 M(+1.8%) |
| Mar 2016 | - | $24.00 M(-30.2%) | $120.91 M(+4.5%) |
| Dec 2015 | $107.49 M | $34.40 M(-2.4%) | $115.66 M(+18.9%) |
| Sept 2015 | - | $35.24 M(+29.2%) | $97.29 M(+3.0%) |
| June 2015 | - | $27.27 M(+45.4%) | $94.47 M(-7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $18.75 M(+16.9%) | $101.71 M(-0.2%) |
| Dec 2014 | $101.96 M(+64.1%) | $16.04 M(-50.5%) | $101.96 M(-3.2%) |
| Sept 2014 | - | $32.42 M(-6.0%) | $105.35 M(+13.3%) |
| June 2014 | - | $34.51 M(+81.6%) | $92.99 M(+23.3%) |
| Mar 2014 | - | $19.00 M(-2.2%) | $75.43 M(+21.4%) |
| Dec 2013 | $62.13 M(+34.8%) | $19.42 M(-3.2%) | $62.13 M(+7.4%) |
| Sept 2013 | - | $20.06 M(+18.4%) | $57.86 M(+20.5%) |
| June 2013 | - | $16.95 M(+197.4%) | $48.02 M(+8.5%) |
| Mar 2013 | - | $5.70 M(-62.4%) | $44.26 M(-3.9%) |
| Dec 2012 | $46.08 M(+9.3%) | $15.15 M(+48.1%) | $46.08 M(+1.8%) |
| Sept 2012 | - | $10.23 M(-22.4%) | $45.26 M(-1.0%) |
| June 2012 | - | $13.19 M(+75.6%) | $45.73 M(-5.9%) |
| Mar 2012 | - | $7.51 M(-47.6%) | $48.61 M(+15.3%) |
| Dec 2011 | $42.17 M(-10.5%) | $14.33 M(+33.8%) | $42.17 M(-6.0%) |
| Sept 2011 | - | $10.71 M(-33.4%) | $44.84 M(-1.8%) |
| June 2011 | - | $16.07 M(+1404.6%) | $45.67 M(+12.3%) |
| Mar 2011 | - | $1.07 M(-93.7%) | $40.67 M(-13.7%) |
| Dec 2010 | $47.11 M(+1.8%) | $17.00 M(+47.4%) | $47.11 M(+12.4%) |
| Sept 2010 | - | $11.53 M(+4.1%) | $41.90 M(+7.3%) |
| June 2010 | - | $11.08 M(+47.5%) | $39.05 M(+1.7%) |
| Mar 2010 | - | $7.51 M(-36.3%) | $38.40 M(-17.0%) |
| Dec 2009 | $46.26 M(+35.7%) | $11.78 M(+35.7%) | $46.26 M(+11.9%) |
| Sept 2009 | - | $8.68 M(-16.7%) | $41.35 M(-4.2%) |
| June 2009 | - | $10.43 M(-32.1%) | $43.19 M(+4.2%) |
| Mar 2009 | - | $15.37 M(+123.7%) | $41.44 M(+21.6%) |
| Dec 2008 | $34.08 M(-15.5%) | $6.87 M(-34.7%) | $34.08 M(-23.8%) |
| Sept 2008 | - | $10.52 M(+21.2%) | $44.76 M(-1.9%) |
| June 2008 | - | $8.68 M(+8.4%) | $45.64 M(+6.6%) |
| Mar 2008 | - | $8.01 M(-54.3%) | $42.80 M(+6.2%) |
| Dec 2007 | $40.31 M(+67.1%) | $17.54 M(+53.8%) | $40.31 M(+14.4%) |
| Sept 2007 | - | $11.41 M(+95.3%) | $35.24 M(+13.3%) |
| June 2007 | - | $5.84 M(+5.9%) | $31.11 M(+23.1%) |
| Mar 2007 | - | $5.52 M(-55.8%) | $25.27 M(+27.9%) |
| Dec 2006 | $24.13 M(-23.7%) | $12.48 M(+71.5%) | $19.75 M(+171.5%) |
| Sept 2006 | - | $7.28 M | $7.28 M |
| Dec 2005 | $31.60 M(+5.0%) | - | - |
| Dec 2004 | $30.10 M(+22.5%) | - | - |
| Dec 2002 | $24.57 M | - | - |
FAQ
- What is Emergent BioSolutions annual cost of goods sold?
- What is the all time high annual cost of goods sold for Emergent BioSolutions?
- What is Emergent BioSolutions annual cost of goods sold year-on-year change?
- What is Emergent BioSolutions quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly cost of goods sold year-on-year change?
- What is Emergent BioSolutions TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Emergent BioSolutions?
- What is Emergent BioSolutions TTM cost of goods sold year-on-year change?
What is Emergent BioSolutions annual cost of goods sold?
The current annual cost of goods sold of EBS is $705.40 M
What is the all time high annual cost of goods sold for Emergent BioSolutions?
Emergent BioSolutions all-time high annual cost of goods sold is $748.10 M
What is Emergent BioSolutions annual cost of goods sold year-on-year change?
Over the past year, EBS annual cost of goods sold has changed by +$12.30 M (+1.77%)
What is Emergent BioSolutions quarterly cost of goods sold?
The current quarterly cost of goods sold of EBS is $122.60 M
What is the all time high quarterly cost of goods sold for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly cost of goods sold is $296.10 M
What is Emergent BioSolutions quarterly cost of goods sold year-on-year change?
Over the past year, EBS quarterly cost of goods sold has changed by -$54.20 M (-30.66%)
What is Emergent BioSolutions TTM cost of goods sold?
The current TTM cost of goods sold of EBS is $748.40 M
What is the all time high TTM cost of goods sold for Emergent BioSolutions?
Emergent BioSolutions all-time high TTM cost of goods sold is $804.70 M
What is Emergent BioSolutions TTM cost of goods sold year-on-year change?
Over the past year, EBS TTM cost of goods sold has changed by +$7.60 M (+1.03%)